During the past few years, it has been previously reported that high levels of activity of CCND1 polymorphisms could affect the development and progression of certain cancers of humans, such as esophageal squamous cell carcinoma [27], lung cancer [28], breast cancer [29], pancreatic cancer [30] and other cancer types in different ethnicities. The gene discussed is CCND1; the disease is lung carcinoma.